Get started
Mesoblast Limited Sponsored ADRMesoblast Limited Sponsored ADRMesoblast Limited Sponsored ADR

Mesoblast Limited Sponsored ADR

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.99 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.85 USD
Net income (FY)
‪−101.97 M‬ USD
Revenue (FY)
‪17.17 M‬ USD
Shares float
—
Beta (1Y)
1.72

About Mesoblast Limited


Sector
Health Technology
Industry
Biotechnology
CEO
Silviu Itescu
Website
mesoblast.com
Headquarters
Melbourne
Founded
2004
IPO date
Dec 16, 2004
Identifiers
3
ISIN US5907174016
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Check out other big names from the same industry as MESO.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IBB
iShares Biotechnology ETF
Weight
0.09%
Market value
‪7.99 M‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.06%
Market value
‪562.61 K‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.06%
Market value
‪562.61 K‬
USD
BIGT
L&G Pharma Breakthrough UCITS ETF
Weight
2.79%
Market value
‪560.47 K‬
USD
SBIO
Invesco NASDAQ Biotech UCITS ETF
Weight
0.06%
Market value
‪257.55 K‬
USD
APIE
ActivePassive International Equity ETF
Weight
0.01%
Market value
‪63.13 K‬
USD
203780
MIRAE ASSET TIGER NASDAQ BIO ETF
Weight
0.06%
Market value
‪45.34 K‬
USD
IBBQ
Invesco Nasdaq Biotechnology ETF
Weight
0.06%
Market value
‪42.17 K‬
USD
BIB
ProShares Ultra Nasdaq Biotechnology
Weight
0.04%
Market value
‪36.62 K‬
USD
XGEN
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD
Weight
0.29%
Market value
‪18.78 K‬
USD
00678
Capital Nasdaq Biotechnology Index ETF
Weight
0.02%
Market value
‪2.16 K‬
USD

Explore more ETFs